Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
China
Countries of investment
  • China
  • USA
Investment stages
  • Seed
Industries
    About
    Morningside invests in private equity and venture capital within innovative science and technology sectors while maintaining a strong commitment to social responsibility.
    Min check size
    $500K
    Max check size
    $5M
    Fund size
    NPS

    Investment Thesis

    Morningside invests in early stage companies in the life sciences and technology sectors, with a focus on companies developing transformative medical and tech solutions.
    Lead investor
    Co Invest
    Number of exits
    Preferred contact method

    Manager's Experience

    With a robust background in venture capital, the fund manager has successfully executed over 50 deals, primarily in the technology and healthcare sectors across Asia. Their investment strategy emphasizes a data-driven approach, aiming to identify high-growth potential companies at the early and growth stages. Notable exits showcase a keen ability to navigate complex markets and maximize returns, reflecting a commitment to strategic, operator-first partnerships. This experience positions the manager as a prominent player in the competitive landscape of innovative investment.

    Team

    Sherr

    Scott Coleridge

    Richard Liu

    Gerald Chan

    Eric Tsao

    David Bates

    Charles Griffith

    Brian Pawlik

    Fund number
    Vintage Year
    Net Internal Rate of Return
    Investment Multiple
    Capital Allocation
    Management Fee
    Carried Interest
    AUM
    Follow-on Investments
    Graduation Rate
    Write-Off Ratio
    Last profile update timestamp